Literature DB >> 2422813

Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies.

J R Dantas, Y Okuno, H Asada, M Tamura, M Takahashi, O Tanishita, Y Takahashi, T Kurata, K Yamanishi.   

Abstract

Viruses causing hemorrhagic fever with renal syndrome (HFRS) encode two glycoproteins, G1 and G2. For determination of the biological functions of these glycoproteins, we isolated 15 hybridomas secreting monoclonal antibodies directed against the glycoproteins of the B-1 and Hantaan viruses (HV). From results of neutralizing and hemagglutination inhibition (HI) tests, and studies on the antigenic reactivities of the antibodies with other HV-related viruses by immunofluorescence, we classified these hybridoma clones into two groups producing antibodies to the G1 proteins of the B-1 virus, six groups producing antibodies to G2 proteins of the B-1 virus, and four groups producing antibodies to the G2 protein of HV. Of the antibodies to G2 produced by 12 clones, groups A and B had high HI activity with HV-related virus cross-reactivity and moderate neutralizing activity, group C had moderate HI activity with virus specificity but low neutralizing activity, group G had high neutralizing activity and low HI activity, and five other groups had little or no HI or neutralizing activity. Group A reacting with G1 protein had low level of both neutralizing and HI activity, while group B had no HI activity. One clone of monoclonal antibody had high neutralizing activity and no HI activity, but it did not react with either polypeptide by immunoprecipitation followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis or by the immunoblotting method. These data suggest that both glycoproteins are the targets of neutralizing antibodies. Furthermore, the results indicate that the antigenic determinants with hemagglutination activity are mainly on the G2 protein, and that the domains related to neutralizing activity and to HI activity are separate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422813     DOI: 10.1016/0042-6822(86)90058-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.

Authors:  C S Schmaljohn; Y K Chu; A L Schmaljohn; J M Dalrymple
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

3.  Virus-specific proteins and RNAs from cells infected with hemorrhagic fever with renal syndrome (HFRS) viruses derived from endemic areas of the U.S.S.R.

Authors:  I S Lukashevich; E A Tkachenko; N N Lemeshko; G V Rezapkin; T A Stelmakh; A J Pashkov; E P Stchesljenok
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Comparison of immunofluorescence and hemagglutination inhibition tests and enzyme-linked immunosorbent assay for detection of serum antibody in rats infected with hemorrhagic fever with renal syndrome virus.

Authors:  Y Takahashi; Y Okuno; T Yamanouchi; N Takada; K Yamanishi
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

5.  DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

Authors:  J W Hooper; D M Custer; E Thompson; C S Schmaljohn
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Phage display selection of cyclic peptides that inhibit Andes virus infection.

Authors:  Pamela R Hall; Brian Hjelle; Hadya Njus; Chunyan Ye; Virginie Bondu-Hawkins; David C Brown; Kathleen A Kilpatrick; Richard S Larson
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

7.  Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.

Authors:  Tobias Manigold; Andrés Mori; Rebecca Graumann; Elena Llop; Valeska Simon; Marcela Ferrés; Francisca Valdivieso; Constanza Castillo; Brian Hjelle; Pablo Vial
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

8.  Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization.

Authors:  A Lundkvist; B Niklasson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala.

Authors:  S L Ruo; A Sanchez; L H Elliott; L S Brammer; J B McCormick; S P Fisher-Hoch
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  New York 1 and Sin Nombre viruses are serotypically distinct viruses associated with hantavirus pulmonary syndrome.

Authors:  I Gavrilovskaya; R LaMonica; M E Fay; B Hjelle; C Schmaljohn; R Shaw; E R Mackow
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.